EGFR and colorectal carcinoma: Through binding to EGFR to activate the downstream RAS/RAF/MEK/ERK signaling pathway, Sdc-1 promotes the acceleration of CRC cells from the chemosensitive G1 phase to the chemoresistant S phase [96, 97].